Indian Pharma Sector Poised for Explosive Growth, Targets $130 Billion by 2030

India's pharmaceutical industry is on track for unprecedented expansion, with projections indicating a market value of $130 billion by 2030. The sector is experiencing a transformative phase driven by strategic mergers and acquisitions, primarily backed by private equity. This consolidation empowers companies to scale operations, diversify into new therapies, and optimize supply chains to address pricing pressures and ensure sustainable growth. Government initiatives like the Production Linked Incentive (PLI) scheme and the National Digital Health Mission are further accelerating industry growth by boosting domestic manufacturing and creating a world-class healthcare ecosystem. With these developments, India is poised to strengthen its position as a global pharmaceutical powerhouse.
Source: Express Pharma